New Key Statistics Module, Z-Score and F-Score
OTCPK:PBIGF Key Ratios
| Market Cap $ M | 48.77 |
| Enterprise Value $ M | 37.11 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.09 |
| Price/Sales | -- |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.13 |
| Beneish M-Score | -1.74 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -28.20 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.95 |
| EV-to-EBITDA | -0.96 |
| PEG | -- |
| Shares Outstanding M | 350.07 |
| Net Margin (%) | -88,868.18 |
| Operating Margin % | -98,777.27 |
| Pre-tax Margin (%) | -88,868.18 |
| Quick Ratio | 7.22 |
| Current Ratio | 7.22 |
| ROA % (ttm) | -126.14 |
| ROE % (ttm) | -158.12 |
| ROIC % (ttm) | -1,298.67 |
| Dividend Yield % | -- |
| Altman Z-Score | -5.12 |
PBIGF Number of Guru Trades
PBIGF Volume of Guru Trades
Gurus Latest Trades with OTCPK:PBIGF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:PBIGF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Paradigm Biopharmaceuticals Ltd Insider Transactions
No Available Data
News about OTCPK:PBIGF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers